[HTML] nih.gov

[HTML][HTML] Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer

DV Balaban, FS Marin, G Manucu… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from
cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been …
被引用次数：8 相关文章
[PDF] researchgate.net

[PDF][PDF] WJCO

DV Balaban, FS Marin, G Manucu, A Zoican… - World, 2022 - researchgate.net
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from
cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been …

Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer.

DV Balaban, FS Marin, G Manucu, A Zoican… - World Journal of …, 2022 - europepmc.org
Background Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from
cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been …

Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer

DV Balaban, FS Marin, G Manucu… - World journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from
cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been …

Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer.

DV Balaban, FS Marin, G Manucu, A Zoican… - World Journal of …, 2022 - europepmc.org
Background Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from
cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been …